MoneyWorks4Me

Divi's Laboratories informs about schedule of analyst meeting

21 Aug 2019 Evaluate

Pursuant to Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Divi's Laboratories has informed about the schedule of meeting(s) with the Analyst(s)/ investor(s): Axis Capital & others to be held on 22 August, 2019. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1759.10
Dr. Reddys Labs. 1230.50
Cipla 1313.70
Lupin 1946.00
Zydus Lifesciences 1139.00
View more..